Interest Expense of Transcode Therapeutics, Inc. from 30 Jun 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Transcode Therapeutics, Inc. quarterly and annual Interest Expense in USD history and change rate from 30 Jun 2020 to 31 Mar 2025.
  • Transcode Therapeutics, Inc. Interest Expense for the quarter ending 31 Mar 2025 was $114, a 99% decline year-over-year.
  • Transcode Therapeutics, Inc. Interest Expense for the twelve months ending 31 Mar 2025 was $17,221, a 67% decline year-over-year.
  • Transcode Therapeutics, Inc. annual Interest Expense for 2024 was $26,813, a 52% decline from 2023.
  • Transcode Therapeutics, Inc. annual Interest Expense for 2023 was $55,899, a 75% increase from 2022.
  • Transcode Therapeutics, Inc. annual Interest Expense for 2022 was $31,986, a 66% decline from 2021.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Transcode Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $17,221 $114 -$9,592 -99% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $26,813 $1,833 -$15,512 -89% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $42,325 $10,792 -$6,490 -38% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $48,815 $4,482 -$3,361 -43% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $52,176 $9,706 -$3,723 -28% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $55,899 $17,345 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $17,282 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $7,843 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $13,429 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2023 Q3
Q4 2021 $95,070 $1 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $333 -$279,944 -100% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $41,966 +$6,316 +18% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $52,770 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q3 2020 $280,277 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $35,650 01 Apr 2020 30 Jun 2020 10-Q 23 Aug 2021 2021 Q2

Transcode Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $26,813 -$29,086 -52% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $55,899 +$23,913 +75% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $31,986 -$63,084 -66% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $95,070 -$299,503 -76% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $394,573 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.